CTI BIOPHARMA CORP·4

Jan 3, 7:21 PM ET

CTI BIOPHARMA CORP 4

4 · CTI BIOPHARMA CORP · Filed Jan 3, 2017

Insider Transaction Report

Form 4
Period: 2016-12-31
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2016-12-31$0.30/sh+5,000$1,523310,000 total
Footnotes (1)
  • [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan. The number of shares purchased was before giving effect to the January 1, 2017 reverse stock split.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT